Semaglutide and methotrexate: what you need to ask your prescriber

You're managing a complex condition and wondering if Wegovy fits into the picture

Perhaps you take methotrexate weekly for rheumatoid arthritis, psoriasis or another immune-mediated condition. You've heard that semaglutide can support meaningful weight loss, and your rheumatologist or GP has never specifically said the two can't be used together. That gap in guidance can feel like a green light. It isn't quite that simple, but it doesn't have to be a barrier either.

The reason prescribers think carefully here comes down to how semaglutide works at a mechanical level. As a GLP-1 receptor agonist, it slows gastric emptying: food and oral medicines move through the stomach more slowly than usual. For most medicines this produces only a modest and clinically manageable change in the speed of absorption. Methotrexate, however, is a medicine where concentration and timing already vary considerably between individuals, and where small shifts in absorption can have practical significance, particularly at higher doses used for inflammatory conditions. You can read more about how semaglutide acts on the body if you want the mechanistic detail before your consultation.

To be clear: the current evidence does not establish that semaglutide and methotrexate interact harmfully or that the combination is contraindicated. What it does mean is that this is precisely the kind of concurrent medication that belongs in a thorough clinical review rather than being quietly omitted from a health questionnaire.

What the clinical evidence actually shows, and where it is silent

When Wegovy was evaluated in the large STEP clinical trials, participants on immunosuppressant therapies were generally excluded or carefully screened, so head-to-head data on this specific combination is limited. The NHS medicines page for semaglutide lists the medicines most likely to interact with it, focusing primarily on oral contraceptives and other medicines with narrow absorption windows. Methotrexate does not appear on a short list of flagged interactions, which is reassuring, but absence from an interaction list is not the same as a formal safety assessment in combination.

Methotrexate itself is renally cleared, and semaglutide can occasionally cause dehydration through gastrointestinal side effects, particularly in the early weeks of treatment. Dehydration reduces renal clearance, which matters for a medicine like methotrexate that depends on the kidneys to excrete it safely. This isn't a reason to avoid the combination; it is a reason to understand it and to have a plan, drinking enough fluid, knowing the symptoms of methotrexate toxicity, and keeping your rheumatology or dermatology team in the loop alongside whoever prescribes your semaglutide.

If you're also curious about other medicines that need careful consideration alongside semaglutide, that page covers the broader interaction picture in detail.

Practical steps if you're taking methotrexate and want to start Wegovy

List everything. That sounds obvious, but a surprising number of people don't mention their methotrexate when filling in a weight-management questionnaire, either because they see it as a separate specialty medicine or because they assume someone else will check. At nume (sorry, at a service like ours) a prescriber reads every consultation personally. Every concurrent medication is part of what they assess.

Your prescriber will want to know: your dose of methotrexate, how long you've been on it, whether your blood tests have been stable, which condition it's treating, and who else is monitoring you. They may want a letter from your specialist, or at minimum they'll note who to contact if any concern arises. That's standard clinical practice, not a complication.

If treatment is approved, the early weeks of semaglutide are when the gastric-emptying effect is most pronounced. Keeping up with your methotrexate monitoring bloods matters during this period. And if you experience significant nausea or vomiting (common in the first few weeks of starting semaglutide) staying well hydrated is especially important given methotrexate's renal excretion pathway. The MHRA Drug Safety Updates index is worth bookmarking for any new safety communications that emerge as both medicines are used more widely together.

For context on Wegovy's clinical profile and what the treatment involves, the semaglutide overview page is a solid starting point, and if you're weighing up costs as part of your decision, the Wegovy cost page sets out the private market picture honestly. Neither replaces a conversation with a prescriber who knows your full history.

At nume, every consultation is reviewed personally by a GPhC-registered Independent Prescriber, a real clinician reads your answers, checks your medication list, and makes a clinical decision. If you take methotrexate, that's exactly the kind of thing they're trained to consider. When treatment is approved, it's dispatched the same day and delivered by DPD the next working day in plain, unbranded packaging, nothing on the outside to suggest what's inside.